当前位置: 首页 > 期刊 > 《中国现代医生》 > 2019年第2期
编号:13328358
消瘀泄浊饮对造影剂肾病大鼠保护作用的实验研究(4)
http://www.100md.com 2019年1月15日 《中国现代医生》 2019年第2期
     [16] Zhao H,Yenari MA,Cheng D,et al. Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity[J]. Journal of Neurochemistry,2003,85(4):1026-1036.

    [17] Hubbard PA,Moody CL,Murali R. Allosteric modulation of Ras and the PI3K/AKT/mTOR pathway:emerging therapeutic opportunities[J]. Frontiers in Physiology,2014, 5:478.

    [18] Dormond O,Madsen JC,Briscoe DM. The effects of mTOR-Akt interactions on anti-apoptotic signaling in vascular endothelial cells[J]. Journal of Biological Chemistry, 2007,282(32):23679.

    [19] Zhao G,Han Y,Hu Y,et al. Targeting HO-1 by Epigallocatechin-3-Gallate Reduces Contrast-Induced Renal Injury via Anti-Oxidative Stress and Anti-Inflammation Pathways[J]. Plos One,2016,11(2):e0149032.

    [20] Michael A,Faga T,Pisani A,et al. Molecular Mechanisms of Renal Cellular Nephrotoxicity due to Radiocontrast Media[J]. Biomed Research International,2014, (6):249810.

    [21] He X,Yang J,Li L,et al. Atorvastatin protects against contrast-induced nephropathy via anti-apoptosis by the upregulation of Hsp27in vivoandin vitro[J]. Molecular Medicine Reports,2017,15(4):1963-1972.

    (收稿日期:2018-07-26), 百拇医药(陆明 胡鹏飞 林冬铭 黄抒伟)
上一页1 2 3 4